Abstract
The protein encoded by the murine double minute 2 (Mdm2) gene inactivates the function of the tumor suppressor p53. The targeted expression of the mdm2 transgene (BLGmdm2) to the mammary epithelium disrupts the cell cycle, causing multiple rounds of DNA synthesis without proper cell division and consequently poor mammary gland development. These phenotypes in the mammary epithelia of the transgenic mice are not dependent on either p53 or the transcription factor E2F1, as mice null for these genes carrying the BLGmdm2 transgene exhibit similar defects to mice carrying the BLGmdm2 transgene alone. p19ARF, an alternative splice product of the INK4a/ARF locus, has been shown to interact directly with MDM2. Therefore, BLGmdm2 transgenic mice null for p19ARF were created to gain insight into the mechanism by which mdm2 overexpression disrupts the cell cycle. The BLGmdm2 phenotype in the absence of p19ARF was worse than BLGmdm2 mice and visible as early as day 15 of pregnancy. By day 5 of lactation the phenotype was very pronounced. Histological analysis of the mammary gland showed a decrease in ductal branching, smaller and fewer lobuloalveolar structures, and a decrease in luminal secretions. Multinucleated and enlarged cells were present due to continued replication in the absence of cytokinesis. Thus, the absence of p19ARF in this in vivo system enhanced the defect caused by mdm2 overexpression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Boyd MT, Vlatkovic N, Haines DS . 2000 J. Biol. Chem. 275: 31883–31890
Chen J, Marechal V, Levine AJ . 1993 Mol. Cell. Biol. 13: 4107–4114
deStanchina E, McCurrach ME, Zindy F, Shieh S-Y, Ferbeyre G, Samuelson AV, Prives C, Roussel MJ, Sherr CJ, Lowe SW . 1998 Genes Dev. 12: 2434–2442
Dahmann C, Diffley JFX, Nasmyth KA . 1995 Curr. Biol. 5: 1257–1269
Evans SC, Viswanathan M, Grier JD, Narayana M, El-Naggar AK, Lozano G . 2001 Oncogene 20: 4041–4049
Fuchs SY, Adler V, Buschmann T, Wu X, Ronai Z . 1998 Oncogene 17: 2543–2547
Gavrieli Y, Sherman Y, Ben-Sasson SA . 1992 J. Cell Biol. 119: 493–501
Haupt Y, Maya R, Kazaz A, Oren M . 1997 Nature 387: 296–299
Honda R, Tanaka H, Yasuda H . 1997 FEBS Lett. 420: 25–27
Jones SN, Roe AE, Donehower LA, Bradley A . 1995 Nature 378: 206–208
Jones SN, Hancock AR, Vogel H, Donehower LA, Bradley A . 1998 Proc. Natl. Acad. Sci. USA 95: 15608–15612
Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ . 1997 Cell 91: 649–659
Kamijo T, Bodner S, van de Kamp E, Randle DH, Sherr CJ . 1999 Cancer Res. 59: 2217–2222
Kubbutat MHG, Jones SN, Vousden KH . 1997 Nature 387: 299–303
Kucera GT, Bortner DM, Rosenberg MP . 1996 Dev. Biol. 173: 162–173
Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW, Vogelstein B . 1993 Cancer Res. 53: 2231–2234
Lundgren K, Montes de Oca Luna R, McNeill YB, Emerick EP, Spencer B, Barfield CR, Lozano G, Rosenberg MP, Finley CA . 1997 Genes Dev. 11: 714–725
Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rollins BJ, Sidransky D . 1995 Cancer Res. 55: 2995–2997
Marchetti A, Buttitta F, Girlando S, Palma PD, Pellegrini S, Fina P, Doglioni C, Bevilacqua G, Barbareschi M . 1995 J. Pathol. 175: 31–38
Marechal V, Elenbaas B, Piette J, Nicolas J-C, Levine AJ . 1994 Mol. Cell. Biol. 14: 7414–7420
McCann AH, Kirley A, Carney DN, Corbally N, Magee HM, Keating G, Dervan PA . 1995 Br. J. Cancer. 71: 981–985
McGarry TJ, Kirschner MW . 1998 Cell 93: 1043–1053
Momand J, Zambetti GP, Olson DC, George D, Levine AJ . 1992 Cell 69: 1237–1245
Momand J, Zambetti GP . 1997 J. Cell. Biochem. 64: 343–352
Montes de Oca Luna R, Wagner DS, Lozano G . 1995 Nature 378: 203–206
Nakayama T, Toguchida J, Wadayama B, Kanoe H, Kotoura Y, Sasaki MS . 1995 Int. J. Cancer 64: 342–346
Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B . 1992 Nature 358: 80–83
Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee H-W, Cordon-Cardo C, DePinho RA . 1998 Cell 92: 713–723
Quelle DE, Zindy F, Ashmun RA, Sherr CJ . 1995 Cell 83: 993–1000
Reinke V, Bortner DM, Amelse LL, Lundgren K, Rosenberg MP, Finley CA, Lozano G . 1999 Cell Growth Diff. 10: 147–154
Ruas M, Peters G . 1998 Biochim. Biophys. Acta. 1378: F115–177
Rugh R . 1968 New York: Burgess Publishing Company pp 41–43
Serrano M, Lee H-W, Chin L, Cordon-Cardo C, Beach D, DePinho R . 1996 Cell 85: 27–37
Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Perry D, Peters G, Kamb A . 1995 Cancer Res. 55: 2988–2994
Xiao Z-X, Chen J, Levine AJ, Modjtahedl N, Xing J, Sellers WR, Livingston DM . 1995 Nature 375: 694–697
Zhang Y, Xiong Y, Yarbrough WG . 1998 Cell 92: 725–734
Zhang Y, Xiong Y . 2000
Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF . 1998 Genes Dev. 12: 2424–2433
Acknowledgements
We thank Charles Sherr and Martine Roussel for providing the p19ARF mice. We are grateful to John Parant and Tomoo Iwakuma for critical reading of the manuscript. This work was supported by a grant from the NIH, CA47296, to G Lozano and the Cancer Center Support Grant, CA16672.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Foster, C., Lozano, G. Loss of p19ARF enhances the defects of Mdm2 overexpression in the mammary gland. Oncogene 21, 3525–3531 (2002). https://doi.org/10.1038/sj.onc.1205441
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205441
Keywords
This article is cited by
-
Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development
Oncogene (2004)
-
Limited role of N-terminal phosphoserine residues in the activation of transcription by p53
Oncogene (2004)
-
Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis
Oncogene (2003)